Skip to Main Content

Paper Details

Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
Clin Cancer Res
24
2018
Author NameAffiliation
Shilpa BhatiaUniversity of Colorado Denver
Ayman OweidaUniversity of Colorado Denver
Andy PhanUniversity of Colorado Denver
Antonio JimenoUniversity of Colorado Denver
Sana D KaramUniversity of Colorado Denver
  • 1 - 5

Datasets

Release 1.2